Indivior PLC

LSE:INDV UK Drug Manufacturers - Specialty & Generic
Market Cap
$18.79 Million
GBX154.47 Billion GBX
Market Cap Rank
#39594 Global
#560 in UK
Share Price
GBX1238.00
Change (1 day)
+1.56%
52-Week Range
GBX660.00 - GBX1238.00
All Time High
GBX2481.00
About

Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly … Read more

Indivior PLC (INDV) - Total Assets

Latest total assets as of June 2025: GBX1.45 Billion GBX

Based on the latest financial reports, Indivior PLC (INDV) holds total assets worth GBX1.45 Billion GBX as of June 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Indivior PLC - Total Assets Trend (2011–2024)

This chart illustrates how Indivior PLC’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Indivior PLC - Asset Composition Analysis

Current Asset Composition (December 2024)

Indivior PLC's total assets of GBX1.45 Billion consist of 63.6% current assets and 36.4% non-current assets.

Asset Category Amount (GBX) % of Total Assets
Cash & Equivalents GBX0.00 24.2%
Accounts Receivable GBX254.00 Million 19.3%
Inventory GBX178.00 Million 13.5%
Property, Plant & Equipment GBX0.00 0.0%
Intangible Assets GBX5.00 Million 0.4%
Goodwill GBX2.00 Million 0.2%

Asset Composition Trend (2011–2024)

This chart illustrates how Indivior PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Indivior PLC's current assets represent 63.6% of total assets in 2024, an increase from 58.9% in 2011.
  • Cash Position: Cash and equivalents constituted 24.2% of total assets in 2024, up from 1.3% in 2011.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 24.0% in 2011.
  • Asset Diversification: The largest asset category is accounts receivable at 19.3% of total assets.

Indivior PLC Competitors by Total Assets

Key competitors of Indivior PLC based on total assets are shown below.

Company Country Total Assets
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
USA $67.26 Billion
Kamada
NASDAQ:KMDA
USA $378.79 Million
One World Pharma Inc
OTCQB:OWPC
USA $6.62 Million
Dongwha Pharm.Co.Ltd
KO:000020
Korea ₩654.63 Billion
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
China CN¥27.28 Billion
Yuhan Corp.
KO:000100
Korea ₩3.05 Trillion
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
China CN¥4.97 Billion
Kotra Industries Bhd
KLSE:0002
Malaysia RM363.90 Million

Indivior PLC - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.42 - 1.08

Strong asset utilization - Indivior PLC generates 0.90x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -9.67% - 24.33%

Moderate ROA - For every $100 in assets, Indivior PLC generates $ 0.15 in net profit.

Indivior PLC - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.90 0.85 1.82
Quick Ratio 0.76 0.68 1.69
Cash Ratio 0.00 0.00 0.00
Working Capital GBX-105.00 Million GBX -148.00 Million GBX 543.00 Million

Indivior PLC - Advanced Valuation Insights

This section examines the relationship between Indivior PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 141.02
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) -32.5%
Total Assets GBX1.32 Billion
Market Capitalization $187.94K USD

Valuation Analysis

Below Book Valuation: The market values Indivior PLC's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Indivior PLC's assets decreased by 32.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Indivior PLC (2011–2024)

The table below shows the annual total assets of Indivior PLC from 2011 to 2024.

Year Total Assets Change
2024-12-31 GBX1.32 Billion -32.50%
2023-12-31 GBX1.95 Billion +10.46%
2022-12-31 GBX1.77 Billion -3.44%
2021-12-31 GBX1.83 Billion +19.66%
2020-12-31 GBX1.53 Billion -7.32%
2019-12-31 GBX1.65 Billion +6.79%
2018-12-31 GBX1.55 Billion +7.13%
2017-12-31 GBX1.44 Billion +19.44%
2016-12-31 GBX1.21 Billion +29.03%
2015-12-31 GBX937.00 Million +25.44%
2014-12-31 GBX747.00 Million +75.35%
2013-12-31 GBX426.00 Million -23.52%
2012-12-31 GBX557.00 Million -0.36%
2011-12-31 GBX559.00 Million --